Skip to main content
Clinical Trials/CTRI/2020/03/023752
CTRI/2020/03/023752
Not yet recruiting
未知

Intranasal dexmedetomidine versus intranasal midazolam via mucosal atomization device in Prevention of emergence agitation in pediatric cataract surgery under sevoflurane anaesthesia- A Randomised Controlled Trial

DIRECTOR PGIMER CHANDIGARH0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: Q120- Congenital cataract
Sponsor
DIRECTOR PGIMER CHANDIGARH
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
DIRECTOR PGIMER CHANDIGARH

Eligibility Criteria

Inclusion Criteria

  • ASA 1 and ASA 2 patients undergoing cataract surgery

Exclusion Criteria

  • 1 ORGAN DYSFUCNTION
  • 2 CARDIAC ARRYTHMIAS OR CONGENTIAL DISEASE
  • 3 DEVELEOPMENTAL DELAY
  • 4 NEUROLOGICAL DISEASES
  • 5 ANY ACTIVE URTI
  • 6 CHILDREN AT RISK OF UPPER AIRWAY OBSTRUCTION
  • 7 KNOWN ALLERGY TO DEXMEDTOMIDINE OR MIDAZOLAM

Outcomes

Primary Outcomes

Not specified

Similar Trials